HK Stock Market Move | EDGE MEDICAL-B (02675) rose nearly 20% in the final trading session, Siasun Robot & Automation has already achieved commercialization layout overseas.

EDGE MEDICAL-B(02675) rose nearly 20% at the close, rising 14.27% as of the time of publication, with the stock trading at 39.88 Hong Kong dollars and a turnover of 53.69 million Hong Kong dollars. On the news front, the Chinese Pancreatic Society held its 2026 academic annual meeting in Shanghai recently. During the conference, Edge Medical showcased its independently developed Edge Porous Cavity Laparoscopic Surgery Siasun Robot&Automation at the conference. At the booth, experts and scholars from the fields of pancreatic surgery, hepatobiliary surgery, and digestive surgery engaged in in-depth discussions with the Edge team on topics such as Siasun Robot&Automation system operation experience, complex procedure adaptation, clinical application expansion, and remote surgery collaboration. Public data shows that Edge Medical's Edge Porous Cavity Laparoscopic Surgery Siasun Robot&Automation has been approved for entry in 55 countries and regions in Europe, the Asia-Pacific, the Middle East, Africa, and Central and South America. The single-port laparoscopic surgery Siasun Robot&Automation and the multi-port-sing-port combination products have been approved for entry in 35 countries and regions. By the end of last year, Edge Medical had signed agreements to sell 119 core products globally, with 92 of them signed for sales last year.